Supplementary data: Treatment of androgenetic alopecia with sublingual minoxidil in transgender people receiving testosterone
Published: 21 January 2026| Version 1 | DOI: 10.17632/k4zmx52zgd.1
Contributors:
Gia Tang, Shalem Leemaqz, Bevin Bhoyrul, Samantha Eisman, Michal Kasprzak, Justyna Sicinska, Rod Sinclair, Description
Supplementary Table I: Side effects reported in sublingual minoxidil and placebo groups in the 24 weeks of double-blind, randomized, placebo-controlled part of the clinical study.
Files
Categories
Dermatology, Hair, Hair Disorder, LGBTQIA+